Lexaria Bioscience Corp. (OTCMKTS:LXRP – Get Free Report)’s stock price crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.22 and traded as high as $0.25. Lexaria Bioscience shares last traded at $0.22, with a volume of 2,151,500 shares trading hands.
Lexaria Bioscience Stock Down 10.7 %
The stock’s 50 day moving average is $0.22. The company has a current ratio of 8.52, a quick ratio of 8.01 and a debt-to-equity ratio of 0.01.
Lexaria Bioscience Company Profile
Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. The company has licensed DehydraTECH to various companies operating in the nicotine, pharmaceutical, nutraceutical, and vitamin industries.
Read More
- Five stocks we like better than Lexaria Bioscience
- What are earnings reports?
- Analysts Predict New Highs for Cybersecurity Stock by Christmas
- Why is the Ex-Dividend Date Significant to Investors?
- Nuclear Power Reaches Critical Mass: Top Stocks to Watch Now
- The 3 Best Blue-Chip Stocks to Buy Now
- 2 Energy Stocks Surging on Billion-Dollar DOE Loan Commitments
Receive News & Ratings for Lexaria Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lexaria Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.